Trial Profile
The Effect of 4mg Saroglitazar on Patients of Diabetes Dyslipidemia with Nonalcoholic Fatty Liver Disease for 24 Weeks at Diabetes Care Centre
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2015
Price :
$35
*
At a glance
- Drugs Saroglitazar (Primary)
- Indications Non-alcoholic fatty liver disease
- Focus Therapeutic Use
- 29 Jul 2015 New trial record
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.